Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103.4 USD | +0.53% | -3.55% | +2.55% |
Apr. 23 | Morgan Stanley Adjusts Cardinal Health's Price Target to $114 From $117, Maintains Overweight Rating | MT |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Evolution of the average Target Price on Cardinal Health, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cardinal Health, Inc.
Morgan Stanley | |
Leerink Partners | |
Argus | |
UBS | |
Wells Fargo Securities | |
JPMorgan Chase | |
Deutsche Bank Securities | |
Morningstar | |
Nephron Research | |
TD Cowen | |
Mizuho Securities | |
Baird | |
Evercore ISI | |
Citigroup | |
Barclays | |
Credit Suisse | |
Cowen | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- CAH Stock
- Consensus Cardinal Health, Inc.